These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1403128)

  • 21. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin.
    Metzer WS; Jenkins T
    J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distant effects of local injection of botulinum toxin.
    Lange DJ; Brin MF; Warner CL; Fahn S; Lovelace RE
    Muscle Nerve; 1987; 10(6):552-5. PubMed ID: 3455658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of idiopathic spasmodic torticollis with botulinum-A toxin: a pilot study of 19 patients.
    Lorentz IT; Subramaniam SS; Yiannikas C
    Med J Aust; 1990 May; 152(10):528-30. PubMed ID: 2338926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
    Domzał TM
    Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical radiculopathy following botulinum toxin therapy for cervical dystonia.
    Defazio G; Lepore V; Melpignano C; Lamberti P; Livrea P; Ferrari E
    Funct Neurol; 1993; 8(3):193-6. PubMed ID: 8406138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: a blinded evaluation.
    Racette BA; McGee-Minnich L; Perlmutter JS
    Clin Neuropharmacol; 1999; 22(6):337-9. PubMed ID: 10626093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia.
    Buchman AS; Comella CL; Stebbins GT; Tanner CM; Goetz CG
    Clin Neuropharmacol; 1993 Jun; 16(3):205-10. PubMed ID: 8504437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum A toxin treatment in spasmodic torticollis: report of 56 patients.
    Poungvarin N; Viriyavejakul A
    J Med Assoc Thai; 1994 Sep; 77(9):464-70. PubMed ID: 7706965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
    Jankovic J; Hunter C; Dolimbek BZ; Dolimbek GS; Adler CH; Brashear A; Comella CL; Gordon M; Riley DE; Sethi K; Singer C; Stacy M; Tarsy D; Atassi MZ
    Neurology; 2006 Dec; 67(12):2233-5. PubMed ID: 17190952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of cervical dystonia with botulinum toxins.
    Comella CL; Thompson PD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():16-20. PubMed ID: 16417593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of an EMG mapping study in treating cervical dystonia.
    Van Gerpen JA; Matsumoto JY; Ahlskog JE; Maraganore DM; McManis PG
    Muscle Nerve; 2000 Nov; 23(11):1752-6. PubMed ID: 11054755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indications for botulinum toxin in neurology].
    Ghika J; Küntzer T; Regli F
    Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of botulinum toxin in the treatment of cervical dystonia.
    Poewe W; Wissel J
    Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical dystonia associated with facioscapulohumeral dystrophy: expanding the clinical spectrum?
    Pareés I; Kojovic M; Prasad Korlipara LV; Bhatia KP
    Mov Disord; 2011 Mar; 26(4):765-6. PubMed ID: 21312280
    [No Abstract]   [Full Text] [Related]  

  • 40. Cervical dystonia: improved treatment response to botulinum toxin after referral to a tertiary centre and the use of polymyography.
    Nijmeijer SW; Koelman JH; Standaar TS; Postma M; Tijssen MA
    Parkinsonism Relat Disord; 2013 May; 19(5):533-8. PubMed ID: 23466060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.